PTC Therapeutics PTCT Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's other income, net (note 6)?
- PTC Therapeutics (PTCT) reported other income, net (note 6) of $1.61M in Q1 2026.
- How has PTC Therapeutics's other income, net (note 6) changed year-over-year?
- PTC Therapeutics's other income, net (note 6) increased by 125.5% year-over-year, from -$6.31M to $1.61M.
- What is the long-term trend for PTC Therapeutics's other income, net (note 6)?
- Over 3 years (2021 to 2025), PTC Therapeutics's other income, net (note 6) has grown at a -32.1% compound annual growth rate (CAGR), from -$57.87M to -$18.09M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.